D. Peyramond

3.0k citations
125 papers · 2.0k indexed · h-index 22
Topics
HIV/AIDS drug development and treatment (17 papers)Streptococcal Infections and Treatments (14 papers)HIV/AIDS Research and Interventions (14 papers)

In The Last Decade

D. Peyramond

119 papers receiving 1.9k citations

Peers

D. Peyramond
Comparison fields: 5 of 107
  • Infectious Diseases 1.1k
  • Epidemiology 772
  • Public Health, Environmental and Occupational Health 373
  • Parasitology 304
  • Virology 275
Replace C. Leport with:
C. Leport France
Miguel Górgolas Spain
Susan Fraser United States
Fredy Suter Italy
N. Singh United States
Alan Karstaedt South Africa
Marwan M. Azar United States
Wayne M. Dankner United States
Glenn Wortmann United States
C. Michelet France
D. Peyramond relative to C. Leport France C. Leport's profile →
Citations per field
00.5×1.5×
C. Leport · 1×
Citations per year

Countries citing papers authored by D. Peyramond

Since Specialization
Citations

This map shows the geographic impact of D. Peyramond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Peyramond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Peyramond more than expected).

Fields of papers citing papers by D. Peyramond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Peyramond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Peyramond. The network helps show where D. Peyramond may publish in the future.

Co-authorship network of co-authors of D. Peyramond

This figure shows the co-authorship network connecting the top 25 collaborators of D. Peyramond. A scholar is included among the top collaborators of D. Peyramond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Peyramond. D. Peyramond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 3
3 18
4 17
5 6
6 2
7 10
8 130
9 9
10
[Diagnosis of normal and abnormal delayed hypersensitivity to Candida albicans. Importance of evaluating lymphocyte activation by flow cytometry].
1
11 15
12
[Propionibacterium acnes infectious endocarditis].
16
13 3
14 23
15 33
16 23
17 16
18
[Q fever infectious endocarditis. 3 cases].
2
19
Abcès tuberculeux bilatéral du psoas sans atteinte rachidienne.
1
20
OEdème pulmonaire lésionnel au cours d'une méningite à méningocoques
1

About D. Peyramond

D. Peyramond is a scholar working on Infectious Diseases, Virology and Microbiology, having authored 125 papers that have together received 2.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (17 papers), Streptococcal Infections and Treatments (14 papers) and HIV/AIDS Research and Interventions (14 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Virology (275 citations) and Parasitology (304 citations). D. Peyramond has collaborated with scholars based in France, United States and Canada. Frequent co-authors include A. Boibieux, F. Biron, Pierre‐Jean Weiller, François Janbon, H. Tissot Dupont, Philippe Brouqui, Meyer Nezri, C. Chicheportiche, R Poirier and Didier Raoult. Their work appears in journals such as Blood, Clinical Infectious Diseases and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026